Earnings call transcript: Nike posts Q1 2026 EPS beat, shares sink on weak sales

Nike reported fiscal Q1 2027 EPS of $0.48, beating the $0.44 consensus by $0.04, but revenue fell 4% to $11.21 billion and missed estimates by $140 million. Greater China sales plunged 26%, while Nike Sportswear and Jordan Brand posted low-double-digit and mid-teens declines, respectively; shares fell 6.24% after hours to $32.96. Nike expects fiscal 2027 revenue to decline in the high single digits and EBIT to fall by more than revenue, although its Pace restructuring program targets $2.5 billion of savings, largely realized in fiscal 2029-2030.

Analysis

NKE is entering a classic “earnings quality” trap: deliberate volume cuts can eventually restore full-price sell-through, but the company has now signaled a multi-quarter period where both revenue and EBIT deleverage worsen simultaneously. The key issue is that the cost program’s meaningful savings arrive well after the operating reset, leaving FY27-FY28 exposed to negative estimate revisions and potentially a lower multiple despite the stock’s already depressed level. The November Investor Day is therefore a binary credibility event: investors need a bridge from current earnings power to a credible FY29 margin recovery, not another long-dated savings target.

Competitive read-through is more nuanced than a broad sporting-goods negative. DKS and ASO should benefit near term if Nike’s reduced Jordan/lifestyle allocations shift consumer wallet toward footwear and apparel alternatives, particularly adidas, On Holding (ONON), Deckers’ HOKA (DECK), and New Balance. Conversely, specialty retail partners with meaningful Nike door traffic face lower high-margin launch activity; watch Foot Locker (FL) and JD Sports for wholesale-order commentary. China’s channel consolidation may improve NKE’s eventual pricing architecture, but creates an opening for ANTA, Li Ning and domestic challenger brands to lock in share while Nike reduces digital availability.

Contrarian case: the after-hours reaction may be directionally right but could become technically exhausted if FY27 guidance is already below buyside expectations and the balance sheet sustains the dividend through the reset. That is not yet a long thesis: a turnaround requires evidence that lower supply is producing higher realized prices and cleaner inventories, rather than simply surrendering demand. The near-term risk is a second guidance reset following holiday sell-through and a more severe China contraction; the upside catalyst is tangible gross-margin expansion and performance growth broadening enough to offset lifestyle declines by the November Investor Day or the following two quarters.

Key Decisions for Investors

• Maintain/establish NKE short on failed rallies into the Investor Day, targeting a 10-15% downside over 1-3 months if FY27 EPS consensus remains above management’s implied range. Cover if management provides a credible FY28 revenue stabilization framework, or if quarterly gross margin expands while inventory and wholesale order books normalize.
• Pair trade: long DKS / short NKE for 3-6 months. DKS has potential share-of-wallet and traffic benefits from Nike’s constrained lifestyle/Jordan supply, while NKE absorbs revenue and fixed-cost deleverage; reassess if DKS reports weaker footwear comps or Nike’s channel checks show full-price sell-through improving materially.
• Avoid treating NKE’s dividend as a valuation floor. Monitor dividend-to-free-cash-flow coverage and net cash through the next two reports; a shift from dividend-growth language to merely maintenance language would likely accelerate multiple compression.
• Set a China watch item rather than a direct JD trade: track NKE’s China revenue trajectory and promotional intensity on Tmall/JD. A further sequential deterioration would be negative for NKE but is not automatically bearish JD, whose platform economics can benefit from marketplace share shifts and domestic-brand advertising demand.